Galera Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Galera Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Galera Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 22 %, a 67.4% decline year-over-year.
  • Galera Therapeutics, Inc. annual Return On Equity for 2023 was 50.3 %, a 27.2% decline from 2022.
  • Galera Therapeutics, Inc. annual Return On Equity for 2022 was 69.1 %, a 70.6% decline from 2021.
  • Galera Therapeutics, Inc. annual Return On Equity for 2021 was 235 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 50.3 -18.8 -27.2% Jan 1, 2023 Dec 31, 2023
2022 69.1 -166 -70.6% Jan 1, 2022 Dec 31, 2022
2021 235 +474 Jan 1, 2021 Dec 31, 2021
2020 -239 -304 -470% Jan 1, 2020 Dec 31, 2020
2019 64.6 +39 +152% Jan 1, 2019 Dec 31, 2019
2018 25.6 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.